Free Trial

Zevra Therapeutics (ZVRA) SEC Filings & 10K Form

Zevra Therapeutics logo
$12.79 0.00 (0.00%)
Closing price 07/15/2025 04:00 PM Eastern
Extended Trading
$12.80 +0.01 (+0.07%)
As of 07/15/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Zevra Therapeutics SEC Filings

DateFilerForm TypeView
06/26/2025
3:25 PM
Thompson Rahsaan (Reporting)
ZEVRA THERAPEUTICS, INC. (Subject)
Zevra Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/24/2025
4:28 PM
Thompson Rahsaan (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
8:37 PM
Anderson Thomas (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
8:38 PM
Bode John B (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
8:38 PM
Watton Corey Michael (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
8:39 PM
FAVORITO TAMARA A (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
8:39 PM
Calder Douglas W (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
8:40 PM
DIXON WENDY L (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
8:41 PM
Shih Alvin (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2025
4:21 PM
Mangless Daniel John (Filed by)
ZEVRA THERAPEUTICS, INC. (Subject)
Zevra Therapeutics (Subject)
Form PRRN14A
04/23/2025
4:29 PM
Mangless Daniel John (Filed by)
ZEVRA THERAPEUTICS, INC. (Subject)
Zevra Therapeutics (Subject)
Form DFAN14A
04/21/2025
6:02 AM
ZEVRA THERAPEUTICS, INC. (Subject)
Zevra Therapeutics (Subject)
Form DEFC14A
04/21/2025
6:17 AM
ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
Form DEFA14A
04/10/2025
4:14 PM
Mangless Daniel John (Filed by)
ZEVRA THERAPEUTICS, INC. (Subject)
Zevra Therapeutics (Subject)
Form PREC14A
04/07/2025
3:31 PM
ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
Form DEFA14A
04/07/2025
7:04 AM
ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2025
7:05 PM
Watton Corey Michael (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/31/2025
4:28 PM
ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
Form DEFA14A
03/27/2025
7:30 PM
Quartel Adrian W (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/27/2025
7:31 PM
Quartel Adrian W (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2025
5:06 AM
ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/12/2025
4:23 PM
ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/27/2025
6:38 AM
ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
4:54 PM
McFarlane Neil F. (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
4:55 PM
Clifton R. LaDuane (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
4:55 PM
Schafer Joshua (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
4:57 PM
Sangiovanni Timothy J. (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
3:38 PM
McFarlane Neil F. (Reporting)
ZEVRA THERAPEUTICS, INC. (Subject)
Zevra Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/12/2025
8:32 AM
Adage Capital Management, L.P. (Filed by)
ZEVRA THERAPEUTICS, INC. (Subject)
Zevra Therapeutics (Subject)
Form SCHEDULE 13G
02/10/2025
4:37 PM
McFarlane Neil F. (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
12:23 PM
BlackRock, Inc. (Filed by)
ZEVRA THERAPEUTICS, INC. (Subject)
Zevra Therapeutics (Subject)
Form SCHEDULE 13G/A
02/03/2025
4:19 PM
McFarlane Neil F. (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
4:20 PM
Clifton R. LaDuane (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
4:22 PM
Schafer Joshua (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
4:23 PM
Thompson Rahsaan (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
4:24 PM
Sangiovanni Timothy J. (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
4:28 PM
ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
3:53 PM
Nantahala Capital Management, LLC (Filed by)
ZEVRA THERAPEUTICS, INC. (Subject)
Zevra Therapeutics (Subject)
Form SCHEDULE 13G/A
11/04/2024
1:15 PM
VANGUARD GROUP INC (Filed by)
ZEVRA THERAPEUTICS, INC. (Subject)
Zevra Therapeutics (Subject)
Form SC 13G/A
10/16/2024
3:46 PM
Watton Corey Michael (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
3:17 PM
ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
The Robotics Revolution has arrived … and one $7 stock could take off as a result. (Ad)

Something big is brewing in Washington. According to my research, an executive order from President Trump could be just weeks away. And it holds the potential to trigger one of the most explosive tech booms in US history. At the center of it all? Robots. Not the kind that clean your house or pour you coffee. But the kind that could reshape entire industries, add $1.2 trillion per year to the US economy, and affect 65 million American lives — just in the next year.

This little-known company holds nearly 100 patents and trades for around $7
08/09/2024
3:54 PM
ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
Form 424B5
07/17/2024
4:54 PM
Clifton R. LaDuane (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2024
3:39 PM
Anderson Thomas (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ZVRA) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners